Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Lungenfacharztzentrum Wiesbaden BAG

Research site

Germany An den Quellen 10, 65183 Wiesbaden, Germany

  • 2 trials recruiting
  • Asthma · Bronchiectasis · Chronic obstructive pulmonary disease
  • Adults and children

About Specializations

Lungenfacharztzentrum Wiesbaden BAG in Wiesbaden, Germany specialises in clinical trials of conditions such as Asthma, Bronchiectasis, Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

The research at Lungenfacharztzentrum Wiesbaden BAG concentrates on respiratory tract diseases, specifically exploring new treatment strategies for Chronic Obstructive Pulmonary Disease (COPD) and eosinophilic asthma to enhance patient outcomes and safety.

  • Assessment of triple inhaled therapy versus dual bronchodilation in COPD
  • Evaluation of an add‑on biologic for uncontrolled eosinophilic asthma
  • Investigation of cardiopulmonary outcomes linked to advanced inhaler regimens
  • Comparison of targeted biologic therapy with high‑dose inhaled corticosteroid escalation

These studies, conducted in a non‑commercial health‑care setting in Wiesbaden, Germany, aim to provide clearer evidence for clinicians and improve therapeutic options for patients living with chronic respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
An den Quellen 1065183 WiesbadenGermany
Open in maps ↗
Recruiting now
2 trials
Conditions studied
3

More sites in WiesbadenGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Bronchiectasis

Recruiting

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Chronic obstructive pulmonary disease

Recruiting

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.